Clinical Trials

Accrual Status
Limit to SWOG Trials

1044 Results

View
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9626

A Phase III Trial of Placebo Versus Megestrol Acetate 20 mg/Day Versus Megestrol Acetate 40 mg/Day as Treatment for Symptoms of Ovarian Failure in Women Treated for Breast Cancer
Activated
04-15-1998
Closed
05-01-2000
Closed
Phase
Accrual
49%
Published
SWOG Clinical Trial Number
S9635

A Phase II Trial of 5-fluorouracil Plus 776C85 in Patients With Advanced Resistant Colorectal Cancer
Research Committee(s)
Gastrointestinal Cancer
Activated
04-01-1998
Closed
09-15-2000
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9801

Evaluation of Gemcitabine - Cisplatin Combination Chemotherapy in Esophageal Carcinoma.
Activated
04-01-1998
Closed
06-15-1999
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9720

Phase II Trial of Paclitaxel and Carboplatin with Amifostine in Advanced Recurrent or Refractory Endometrial Adenocarcinoma
Research Committee(s)
Gynecologic Cancer
Activated
02-15-1998
Closed
07-15-2000
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9712

Phase II Trial of Concurrent Carboplatin/VP-16 and Radiation Followed by Paclitaxel (Taxol®) For Poor-Risk Stage III Non-Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
02-15-1998
Closed
06-01-2000
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9800

A Phase II Pilot Trial of CHOP Followed by Rituximab Chimeric Monoclonal Anti-CD20 Antibody for Treatment of Newly Diagnosed Follicular Non-Hodgkin’s Lymphomas
Research Committee(s)
Lymphoma
Activated
02-15-1998
Closed
11-15-1998
Closed
Phase
Accrual
1%
SWOG Clinical Trial Number
S9631

A Cross-Sectional Study to Estimate the Incidence of Endometrial Pathology in Women Receiving Tamoxifen on SWOG-9313 (INT-0137, CALGB 9394, NCCTG 93-30-51)
Research Committee(s)
Breast Cancer
Activated
02-01-1998
Closed
03-01-2000
Closed
Phase
Accrual
72%
Published
SWOG Clinical Trial Number
S9708

Evaluation of Gemcitabine (Gemzar®) in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN).
Activated
12-01-1997
Closed
03-01-1999
Closed
Phase
Accrual
10%
SWOG Clinical Trial Number
SWOG-9507

A Single Arm Phase II Study to Determine the Safety and Efficacy of 4-HPR N-(4-Hydroxyphenyl) Retinamide for Treating Oral Intraepithelial Neoplasia.
Activated
12-01-1997
Closed
03-01-2000
Closed
Phase
Accrual
62%
Published
SWOG Clinical Trial Number
S9701

Phase III Randomized Trial of 12 Months VS 3 Months of Paclitaxel in Patients with Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer Who Attain a Clinically Defined Complete Response (CR) Following Platinum/Paclitaxel-Based Chemotherapy (Intergroup)
Research Committee(s)
Gynecologic Cancer
Activated
11-15-1997
Closed
12-01-2001
Closed
Phase
Accrual
13%
SWOG Clinical Trial Number
S9719

Clonal Hematopoiesis as a Marker of Genetic Damage Pilot Study Following Adjuvant Chemotherapy for Breast Cancer: Pilot Study to Evaluate Incidence, Ancillary to S9623
Research Committee(s)
Breast Cancer
Activated
10-15-1997
Closed
02-01-2001
Closed
Phase
Accrual
4%
SWOG Clinical Trial Number
S9702

Detection of Malignant Cells in the Marrow and Peripheral Blood Progenitor Cell Products of Breast Cancer Patients Enrolled on Intergroup Randomized Study S9623
Research Committee(s)
Breast Cancer
Activated
10-01-1997
Closed
07-15-1999
Closed
Phase
Accrual
90%
Published
SWOG Clinical Trial Number
S9700

A Phase II Trial of Infusional 5-Fluorouracil (5-FU), Calcium Leucovorin (LV), Mitomycin-C (Mito-C), and Dipyridamole (D) in Patients with Locally Advanced Unresected Pancreatic Adenocarcinoma
Research Committee(s)
Gastrointestinal Cancer
Activated
09-15-1997
Closed
06-19-2001
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9704

A Randomized Phase III Trial Comparing Early High Dose Chemoradiotherapy and an Autologous Stem Cell Transplant to Conventional Dose CHOP Chemotherapy Plus Rituximab for CD20+ B Cell Lymphomas(with Possible Late Autologous Stem Cell Transplant) for Patients with Diffuse Aggressive Non-Hodgkin's Lymphoma in the High-Intermediate and High Risk International Classification Prognostic Groups (A BMT Study)
Research Committee(s)
Lymphoma
Activated
09-15-1997
Closed
12-15-2007
Closed
Phase
Accrual
65%
Published
SWOG Clinical Trial Number
S9709

A Phase II Study to Evaluate Transoral CO2 Laser Supraglottic Laryngectomy and Irradiation in Stage I, II and III Squamous Cell Carcinoma of the Supraglottic Larynx
Research Committee(s)
Head and Neck Cancer
Activated
09-15-1997
Closed
12-01-2001
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9706

A Phase II Trial of High Dose Cyclophosphamide Followed by Fludarabine in Patients with Previously Untreated B-Cell Chronic Lymphocytic Leukemia
Research Committee(s)
Leukemia
Activated
09-15-1997
Closed
03-01-1999
Closed
Phase
Accrual
0%
SWOG Clinical Trial Number
S9703

Phase II Trial of Antibiotic Eradication of Helicobacter Pylori and, Failing That, Systemic Chemotherapy with CHOP and Local Therapy with Involved Field Radiation in Patients with Malt Lymphomas
Research Committee(s)
Lymphoma
Activated
09-15-1997
Closed
03-01-1999
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9705

Phase II Trial of Cisplatin, Etoposide and Paclitaxel (Taxol®) With G-CSF in Untreated Patients with Extensive Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
08-15-1997
Closed
07-01-1998
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9632

Enhancing Well-Being During Breast Cancer Recurrence
Activated
06-01-1997
Closed
08-01-1998
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9629

A Phase II Trial of 5-Fluorouracil Plus 776C85 in Patients with Advanced Pancreas Cancer
Activated
05-15-1997
Closed
03-15-1999